Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$3.36 - $5.34 $85,522 - $135,919
-25,453 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$3.3 - $6.49 $30,960 - $60,889
9,382 Added 58.38%
25,453 $141,000
Q2 2021

Aug 16, 2021

BUY
$3.35 - $5.67 $53,837 - $91,122
16,071 New
16,071 $58,000
Q3 2020

Nov 17, 2020

SELL
$7.22 - $9.11 $203,510 - $256,783
-28,187 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$4.93 - $10.26 $29,890 - $62,206
6,063 Added 27.4%
28,187 $244,000
Q1 2020

May 15, 2020

BUY
$2.58 - $6.6 $57,079 - $146,018
22,124 New
22,124 $115,000

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $51.7M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.